10.74 0.00 (0.00%)
After hours: 4:36PM EST
|Bid||10.75 x 300|
|Ask||13.09 x 200|
|Day's range||10.72 - 11.29|
|52-week range||8.07 - 18.00|
|PE ratio (TTM)||N/A|
|Earnings date||1 Mar 2018 - 5 Mar 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||24.00|
A live audio webcast for this conference will be available in the “Investors” section of the Lexicon website at www.lexpharma.com/. Lexicon is a fully integrated biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for patients with serious, chronic conditions. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease.
On a per-share basis, the The Woodlands, Texas-based company said it had a loss of 29 cents. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...